Renishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services technological products and services, and analytical instruments and medical devices worldwide. It operates through two segments: Manufacturing technologies; and Analytical instruments and medical devices. The company offers precision measurement and process control products, such as co-ordinate measuring machine probes, software, retrofits, equator gauging systems, fixtures, machine calibration and optimization, machine tool probes, precision styli for metrology, and smart manufacturing data platform; and position and motion control products comprising interferometric laser, magnetic, and optical encoders. It also provides healthcare products, such as neuromate stereotactic robots, neuroinfuse drug delivery systems, neuroinspire surgical planning software, dixi medical's, and Raman spectrometers; industrial robots; and additive 3D printing manufacturing systems. It serves the aerospace, automotive, consumer electronics, medical and healthcare, heavy, machine builder, energy, and precision manufacturing industries, as well as scientific, research, and analysis industries. The company was incorporated in 1973 and is based in Wotton-under-Edge, the United Kingdom.
Visit company website
5 years, 5 months ago
Renishaw plc is currently in a long term downtrend where the price is trading 11.2% below its 200 day moving average.
From a valuation standpoint, the stock is 32.6% cheaper than other stocks from the Technology sector with a price to sales ratio of 9.2.
Renishaw plc's total revenue sank by 0.0% to $130M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $4M since the same quarter in the previous year.
Finally, its free cash flow grew by 571.1% to $35M since the same quarter in the previous year.
Based on the above factors, Renishaw plc gets an overall score of 2/5.